These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20955274)

  • 1. Effect of a single hemodialysis session on inflammatory markers.
    Bitla AR; Reddy PE; Manohar SM; Vishnubhotla SV; Pemmaraju Venkata Lakshmi Narasimha SR
    Hemodial Int; 2010 Oct; 14(4):411-7. PubMed ID: 20955274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anti-HCV positivity on markers of malnutrition and inflammation in hemodialysis patients.
    Zumrutdal A; Ozer B; Singan M; Micozkadioglu H; Sezer S; Ozdemir FN; Haberal M
    Ren Fail; 2007; 29(1):85-90. PubMed ID: 17365915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality.
    Korevaar JC; van Manen JG; Dekker FW; de Waart DR; Boeschoten EW; Krediet RT;
    J Am Soc Nephrol; 2004 Nov; 15(11):2916-22. PubMed ID: 15504945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study.
    Szklarek-Kubicka M; Fijałkowska-Morawska J; Zaremba-Drobnik D; Uciński A; Czekalski S; Nowicki M
    J Ren Nutr; 2009 Nov; 19(6):487-93. PubMed ID: 19616450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients.
    Terrier N; Senécal L; Dupuy AM; Jaussent I; Delcourt C; Leray H; Rafaelsen S; Bosc JY; Maurice F; Canaud B; Cristol JP
    Hemodial Int; 2005 Apr; 9(2):159-68. PubMed ID: 16191065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
    Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
    Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients.
    McIntyre C; Harper I; Macdougall IC; Raine AE; Williams A; Baker LR
    Clin Nephrol; 1997 Dec; 48(6):371-4. PubMed ID: 9438096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of inflammatory factors and cardiac troponin T in hemodialysis patients.
    Falaknazi K; Bagheri N; Taziki O
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):219-22. PubMed ID: 19237807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low triiodothyronine: a new facet of inflammation in end-stage renal disease.
    Zoccali C; Tripepi G; Cutrupi S; Pizzini P; Mallamaci F
    J Am Soc Nephrol; 2005 Sep; 16(9):2789-95. PubMed ID: 16033857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
    Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
    Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of serum cystatin C with C-reactive protein and apolipoprotein A1 in patients on hemodialysis.
    Samouilidou EC; Grapsa E
    Ren Fail; 2008; 30(7):711-5. PubMed ID: 18704820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
    Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
    Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.